Related Experiment Video
Updated: Jul 11, 2025

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
Published on: January 7, 2019
Comprehensive Analysis of a Competing Endogenous RNA Co-Expression Network in Chronic Obstructive Pulmonary Disease
Jingwei Wang1,2, Bowen Xia3, Ruimin Ma1
1Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.
Purpose:
Chronic obstructive pulmonary disease (COPD) is the main cause of mortality world widely. Non-coding RNAs (lncRNAs) and associated competitive endogenous RNAs (ceRNAs) networks were recently proved to lead to mRNA gene expression downregulation but were still unclear in COPD. This study aims to investigate and elucidate the mechanisms underlying the involvement of ceRNA co-expression networks in COPD pathogenesis.
Methods:
Obtained expression signature of data from the Gene Expression Omnibus database and compared the differentially expression of mRNAs and miRNAs between COPD patients and healthy smokers. Predicted the miRNA-lncRNA and miRNA-mRNA interaction using online library and employed CIBERSORT to measure the proportions of the 22 immune cells in the COPD and control groups.
Results:
Established a ceRNA-network comprising 11 lncRNAs, 5 miRNAs, and 16 mRNAs. Using the weighted correlation network analysis method, we identified hub genes and hub miRNAs and obtained one core sub-network, XIST, FGD5-AS1, KCNQ1OT1, HOXA11-AS, LINC00667, H19, PRKCQ-AS1, NUTM2A-AS1/has-mir-454-3p/ZNF678, PRRG4. COPD patients had different proportions of immune cells than controls, and these variations were associated with the magnitude of pulmonary function parameters.
Conclusion:
The ceRNA-network, particularly the core sub-network, may be a putative goal for COPD, in which specific immune cells were involved.
Insights
This study reveals a competitive endogenous RNA (ceRNA) network involved in chronic obstructive pulmonary disease (COPD) pathogenesis. The identified ceRNA network, including specific immune cells, may offer new therapeutic targets for COPD.
Area of Science:
- Genomics
- Molecular Biology
- Immunology
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading global cause of mortality.
- The role of non-coding RNAs (ncRNAs) and competitive endogenous RNA (ceRNA) networks in COPD pathogenesis remains largely unclear.
- Understanding these molecular mechanisms is crucial for developing effective COPD treatments.
Purpose of the Study:
- To investigate the mechanisms of ceRNA co-expression networks in COPD.
- To identify key long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) involved in COPD.
- To explore the association between the ceRNA network and immune cell infiltration in COPD.
Main Methods:
- Utilized Gene Expression Omnibus (GEO) data to compare gene expression profiles between COPD patients and healthy controls.
- Predicted miRNA-lncRNA and miRNA-mRNA interactions using online databases.
- Employed CIBERSORT to analyze immune cell proportions and correlated them with pulmonary function parameters.
Main Results:
- A ceRNA network consisting of 11 lncRNAs, 5 miRNAs, and 16 mRNAs was established.
- Weighted gene co-expression network analysis identified a core sub-network crucial for COPD.
- Significant differences in immune cell proportions were observed in COPD patients, correlating with disease severity.
Conclusions:
- The identified ceRNA network, especially the core sub-network, represents a potential therapeutic target for COPD.
- Specific immune cells play a role in COPD pathogenesis mediated by the ceRNA network.
- Further research into this ceRNA network could lead to novel diagnostic and therapeutic strategies for COPD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

